Porphyrin lipid-perfluorocarbon nano preparation as well as preparation method and application thereof

A perfluorocarbon and porphyrin lipid technology, which is applied in the field of biomedical materials, can solve the problems of low perfluorocarbon loading capacity, light/acoustic drug aggregation, low generation capacity concentration, etc. Enhanced fluorescence/CT imaging and reduced toxicity and side effects

Active Publication Date: 2021-11-05
PEKING UNIV
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, their O 2 Intracellular H 2 o 2 low concentration limit
In contrast, perfluorocarbons (PFCs) have high biocompatibility and good oxygen solubility, and are expected to be used as artificial blood to deliver oxygen to relieve tumor hypoxia, but PFCs in conventional delivery systems load capacity is usually low,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Porphyrin lipid-perfluorocarbon nano preparation as well as preparation method and application thereof
  • Porphyrin lipid-perfluorocarbon nano preparation as well as preparation method and application thereof
  • Porphyrin lipid-perfluorocarbon nano preparation as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0037] Example 1

[0038] The preparation method of a kind of porphyrin lipid-perfluorooctane bromide nano preparation of the present invention comprises the following steps:

[0039] 1) The porphyrin lipid A (wherein R 1 and R 2 All are C16 alkyl; R 3 is hydroxyl; a=2, b=2; X is NH) (10mmol, PGL lipid) was dissolved in a mixed solvent of chloroform and methanol (volume ratio 9:1), the liquid was dried under reduced pressure to form a thin film, and the vacuum dry overnight;

[0040] 2) Add ultrapure water, hydrate for 30 min in a 60°C water bath, and then use a sonicator to sonicate under ice-bath conditions, so that the lipids are uniformly dispersed in the aqueous solution;

[0041] 3) Add perfluorooctane (350 μL, PFOB) dropwise to the solution in step 2) under ice bath conditions, and use the probe to ultrasonically disperse for 5 min to obtain uniformly dispersed porphyrin lipid-perfluorooctane The alkane nanoformulations can be further removed by centrifugation (100...

Example Embodiment

[0043] Example 2

[0044] The preparation method of a kind of porphyrin lipid-perfluorohexane nano preparation of the present invention comprises the following steps:

[0045] 1) The porphyrin lipid B containing hematoporphyrin photo / acoustic groups (wherein R 1 and R 2 All are C12 alkyl; R 3 is polyethylene glycol; a=2, b=2; X is O) (9.5 mmol) and DSPE-mPEG2000 (0.5 mmol) were dissolved in a mixed solvent of chloroform and methanol (volume ratio 9:1) to reduce Press-spin the liquid to form a thin film, and vacuum dry overnight;

[0046] 2) Add ultrapure water, hydrate for 10 min in a water bath at 45°C, and then use a sonicator to ultrasonically treat it in an ice bath, so that the lipids are uniformly dispersed in the aqueous solution;

[0047] 3) Add perfluorohexane (330 μL) dropwise to the solution in step 2) under ice bath conditions, and use the probe to ultrasonically disperse for 10 min to obtain a uniformly dispersed porphyrin lipid-perfluorohexane nano-formulatio...

Example Embodiment

[0048] Example 3

[0049] The preparation method of a kind of porphyrin lipid-perfluorohexane nano preparation of the present invention comprises the following steps:

[0050] 1) The porphyrin lipid C containing protoporphyrin photo / acoustic groups (wherein R 1 and R 2 All are C18 alkyl; R 3 is polyethylene glycol; a=3, b=3; X is O) (0.5 mmol), DPPC (9.0 mmol) and DSPE-Maleimide (0.5 mmol) dissolved in chloroform and methanol (9:1 by volume) In the mixed solvent of , the liquid was spin-dried under reduced pressure to form a thin film, and vacuum dried overnight;

[0051] 2) Add ultrapure water, hydrate for 20 min in a water bath at 50°C, and then use a sonicator to ultrasonically treat it in an ice bath, so that the lipids are uniformly dispersed in the aqueous solution;

[0052] 3) Add perfluorohexane (352 μL) dropwise to the solution in step 2) under ice bath conditions, and use the probe to ultrasonically disperse for 10 min to obtain a uniformly dispersed porphyrin li...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a porphyrin lipid-perfluorocarbon nano preparation and a preparation method and application thereof. The prepared nano preparation is of a core-shell structure, which comprises a porphyrin liposome membrane layer of a shell and perfluorocarbon of an inner core and can be used as a photosensitizer or sonosensitizer medicine and an oxygen delivery system, the photosensitizer/sonosensitizer medicine and oxygen are synchronously delivered to the tumor, under laser or ultrasonic irradiation, the photodynamic therapy/sonodynamic therapy effect is remarkably enhanced, the hypoxic microenvironment of the tumor is improved, and recurrence and metastasis of the tumor are effectively inhibited. According to the invention, photosensitizer/sonosensitizer medicine are covalently linked in lipid molecules, perfluorocarbon is entrapped through strong hydrophobic acting force, which has the characteristics of high stability, high drug loading capacity, high oxygen carrying capacity, difficulty in leakage and the like, and has a good clinical application prospect in tumor diagnosis and treatment.

Description

technical field [0001] The invention belongs to the field of biomedical materials, and in particular relates to a porphyrin lipid-perfluorocarbon nano-preparation and its preparation method and application. Background technique [0002] Photo / acoustodynamic therapy has attracted increasing attention in clinical cancer treatment research in the past decades. Usually photo / acoustodynamic therapy can transfer energy to O 2 , and then generate cytotoxic reactive oxygen species (ROS), thereby irreversibly destroying the protein or DNA of tumor cells and inducing tumor cell apoptosis. Compared with conventional surgery, chemotherapy, and radiotherapy, photo / acoustic dynamic therapy has the advantages of non-invasiveness, higher controllability, reduced side effects, negligible drug resistance, and precise therapeutic function preserving tumor intervention and replacing tumor ablation. [0003] However, so far, the clinical application of photo / acoustodynamic therapy is still aff...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K41/00A61K33/00A61K47/54A61K47/69A61K49/00A61K49/04A61P35/00A61P35/04
CPCA61K41/0033A61K41/0071A61K33/00A61K47/54A61K47/6929A61K49/0036A61K49/0052A61K49/04A61P35/00A61P35/04A61K2300/00
Inventor 戴志飞梁晓龙
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap